Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Lower melatonin levels are linked to more skin aging.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Ethosomes improve finasteride delivery through skin for hair loss treatment.

Drugs penetrate scalp skin better than abdominal skin, with scalp hair follicles aiding in higher drug delivery.

Aromatase gene variation may increase female hair loss risk.

Nanoparticles don't penetrate intact skin but can enter through pores or damaged skin.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Glycol chitosan hydrogels enable quick, safe 3D cell spheroid formation for various applications.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.